# Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)

> **NCT00707876** · PHASE2 · COMPLETED · sponsor: **AMAG Pharmaceuticals, Inc.** · enrollment: 119 (actual)

## Conditions studied

- Peripheral Arterial Disease (PAD)

## Interventions

- **DRUG:** ferumoxytol
- **DRUG:** ferumoxytol
- **DRUG:** ferumoxytol

## Key facts

- **NCT ID:** NCT00707876
- **Lead sponsor:** AMAG Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09-01
- **Primary completion:** 2010-07-02
- **Final completion:** 2020-08-15
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00707876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00707876, "Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00707876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*